SARA FORMAN: Open Payments
NPI 1902271331 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,404 in 107 payments from 21 companies in 2025. Trend: 2023 $530 · 2024 $1,879 · 2025 $2,404
Food & beverage: $2,315Education: $89
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $612 |
| Madrigal Pharmaceuticals | 7 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $238 |
| Janssen Biotech, Inc. | 9 | $222 |
| GENZYME CORPORATION | 8 | $214 |
| VIVUS LLC | 6 | $117 |
| PFIZER INC. | 5 | $109 |
| Ardelyx, Inc. | 3 | $97 |
| Regeneron Healthcare Solutions, Inc. | 4 | $92 |
| Celltrion USA Inc. | 3 | $91 |
Products named: DUPIXENT, RINVOQ, REZDIFFRA, TREMFYA, ENTYVIO, Linzess, PANCREAZE, CREON.
Industry payments across FL — which companies pay providers there.
